A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.

Clinical trial NCT05875727 · COMPLETED

Trial details

NCT number: NCT05875727
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2023-08-16
Primary completion: 2023-10-02
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.